Investing Ideas
/
Australian Pharmaceuticals & Biotech Sustainable Track Record

Australian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

3 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CTE Cryosite	AU$0.85	0%	39.3%	AU$41.5m	n/a	PE22.5x	n/a	2.4%
NEU Neuren Pharmaceuticals	AU$12.14	-8.9%	-49.5%	AU$1.6b	AU$26.21	PE13.2x	E-9.9%	n/a
EZZ EZZ Life Science Holdings	AU$2.91	10.2%	381.0%	AU$134.3m	AU$5.45	PE19.3x	E17.9%	1.0%

Page 1 of 1